Organism profile and C-reactive protein (CRP) response are different in periprosthetic joint infection in patients with hepatitis.
Arthroplasty
Hepatitis
Periprosthetic joint infection
Septic exchange
Journal
Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043
Informations de publication
Date de publication:
24 Sep 2023
24 Sep 2023
Historique:
received:
18
05
2023
accepted:
01
09
2023
medline:
24
9
2023
pubmed:
24
9
2023
entrez:
24
9
2023
Statut:
aheadofprint
Résumé
Hepatitis B and C are important and relatively common health issues. It is known that many patients who underwent total knee and hip arthroplasty were also diagnosed with hepatitis. These patients are at higher risk of periprosthetic joint infection (PJI). This study aimed to investigate the differences in PJI cases in hepatitis B and C patients. This is a retrospective case-controlled single-center study. A total of 270 patients with hepatitis and non-hepatitis (control group) who underwent one-stage septic exchange to the hip and knee joints were included in the study. All patients' previous surgical histories, infective organisms, C-reactive protein (CRP) values before septic exchange, and demographic data were evaluated. All microbiological and laboratory evaluations were performed separately for knee and hip arthroplasty. The mean CRP levels of Hep B- and C-positive patients, who underwent one-stage septic exchange in the knee joint, were 23.6 mg/L. In the control group, this value was 43.1 mg/L and a statistically significant difference was found between the groups (p = 0.004). Gram-negative organisms were identified in a larger proportion of patients with hepatitis who developed PJI in both hip and knee joints and underwent one-stage septic exchange (p = 0.041/p = 0.044). PJIs caused by Gram-negative bacteria are encountered more frequently in patients with hepatitis than in the control group. In addition, the CRP rise is less in patients with hepatitis compared to PJI cases in the control group. Patient-specific evaluation is required in cases of PJI in patient groups with co-existing hepatitis.
Identifiants
pubmed: 37742285
doi: 10.1007/s00402-023-05059-7
pii: 10.1007/s00402-023-05059-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
McDermott KW, Liang L (2006) Overview of operating room procedures during inpatient stays in U.S. hospitals, 2018: statistical brief #281. Healthcare cost and utilization project (HCUP) statistical briefs
Singh JA, Yu S, Chen L, Cleveland JD (2019) Rates of total joint replacement in the United States: future projections to 2020–2040 using the national inpatient sample. J Rheumatol 46:1134–1140. https://doi.org/10.3899/JRHEUM.170990
doi: 10.3899/JRHEUM.170990
pubmed: 30988126
Kildow BJ, Politzer CS, DiLallo M et al (2018) Short and long-term postoperative complications following total joint arthroplasty in patients with human immunodeficiency virus, hepatitis B, or hepatitis C. J Arthroplasty 33:S86–S92.e1. https://doi.org/10.1016/J.ARTH.2017.10.061
Schweitzer A, Horn J, Mikolajczyk RT et al (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386:1546–1555. https://doi.org/10.1016/S0140-6736(15)61412-X
doi: 10.1016/S0140-6736(15)61412-X
pubmed: 26231459
Gower E, Estes C, Blach S et al (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61:S45–S57. https://doi.org/10.1016/J.JHEP.2014.07.027
doi: 10.1016/J.JHEP.2014.07.027
pubmed: 25086286
Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med. https://doi.org/10.1056/NEJMRA040181
doi: 10.1056/NEJMRA040181
pubmed: 15483283
Kapadia BH, Berg RA, Daley JA et al (2016) Periprosthetic joint infection. Lancet 387:386–394. https://doi.org/10.1016/S0140-6736(14)61798-0
doi: 10.1016/S0140-6736(14)61798-0
pubmed: 26135702
Akgün D, Wiethölter M, Siegert P et al (2022) The role of serum C-reactive protein in the diagnosis of periprosthetic shoulder infection. Arch Orthop Trauma Surg 142:1715–1721. https://doi.org/10.1007/S00402-021-03779-2
doi: 10.1007/S00402-021-03779-2
pubmed: 33515325
Sproston NR, Ashworth JJ (2018) Role of C-reactive protein at sites of inflammation and infection. Front Immunol. https://doi.org/10.3389/FIMMU.2018.00754
doi: 10.3389/FIMMU.2018.00754
pubmed: 30013561
pmcid: 6036124
Wang J, Zhao G, Chen J et al (2019) Association of hepatitis B infection with high-risk complications in total joint arthroplasty. BMC Musculoskelet Disord. https://doi.org/10.1186/S12891-019-2535-Y
doi: 10.1186/S12891-019-2535-Y
pubmed: 31892355
pmcid: 6937651
Parvizi J, Tan TL, Goswami K et al (2018) The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty 33:1309-1314.e2. https://doi.org/10.1016/J.ARTH.2018.02.078
doi: 10.1016/J.ARTH.2018.02.078
pubmed: 29551303
Jenne CN, Kubes P (2013) Immune surveillance by the liver. Nat Immunol 14:996–1006. https://doi.org/10.1038/NI.2691
doi: 10.1038/NI.2691
pubmed: 24048121
Sandler NG, Koh C, Roque A et al (2011) Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology. https://doi.org/10.1053/J.GASTRO.2011.06.063
doi: 10.1053/J.GASTRO.2011.06.063
pubmed: 22062360
Brandolini M, Corbella M, De Silvestri A et al (2015) Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease. Infection 43:561–567. https://doi.org/10.1007/S15010-015-0794-6
doi: 10.1007/S15010-015-0794-6
pubmed: 25976737
Parker R, Im G, Jones F et al (2017) Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study. J Gastroenterol 52:1192–1200. https://doi.org/10.1007/S00535-017-1336-Z
doi: 10.1007/S00535-017-1336-Z
pubmed: 28389732
pmcid: 5666044
Zhai XR, Tong JJ, Wang HM et al (2020) Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol. https://doi.org/10.1186/S12876-020-01473-Y
doi: 10.1186/S12876-020-01473-Y
pubmed: 32993547
pmcid: 7526233
Bjerke-Kroll BT, Christ AB, McLawhorn AS et al (2014) Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile. J Arthroplasty 29:877–882. https://doi.org/10.1016/J.ARTH.2013.09.053
doi: 10.1016/J.ARTH.2013.09.053
pubmed: 24199997
Tsai JC, Sheng WH, Lo WY et al (2015) Clinical characteristics, microbiology, and outcomes of prosthetic joint infection in Taiwan. J Microbiol Immunol Infect 48:198–204. https://doi.org/10.1016/J.JMII.2013.08.007
doi: 10.1016/J.JMII.2013.08.007
pubmed: 24064293
Villa JM, Pannu TS, Theeb I et al (2021) International organism profile of periprosthetic total hip and knee infections. J Arthroplasty 36:274–278. https://doi.org/10.1016/J.ARTH.2020.07.020
doi: 10.1016/J.ARTH.2020.07.020
pubmed: 32828620
Bosco F, Cacciola G, Giustra F et al (2023) Characterizing recurrent infections after one-stage revision for periprosthetic joint infection of the knee: a systematic review of the literature. Eur J Orthop Surg Traumatol. https://doi.org/10.1007/S00590-023-03480-7
doi: 10.1007/S00590-023-03480-7
pubmed: 37668753
pmcid: 10504163
Zimmerli W, Sendi P (2017) Orthopaedic biofilm infections. APMIS 125:353–364. https://doi.org/10.1111/APM.12687
doi: 10.1111/APM.12687
pubmed: 28407423
Tande AJ, Patel R (2014) Prosthetic joint infection. Clin Microbiol Rev 27:302–345. https://doi.org/10.1128/CMR.00111-13
doi: 10.1128/CMR.00111-13
pubmed: 24696437
pmcid: 3993098
Benito N, Mur I, Ribera A et al (2019) The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms. J Clin Med. https://doi.org/10.3390/JCM8050673
doi: 10.3390/JCM8050673
pubmed: 31109070
pmcid: 6572270
Tai DBG, Patel R, Abdel MP et al (2022) Microbiology of hip and knee periprosthetic joint infections: a database study. Clin Microbiol Infect 28:255–259. https://doi.org/10.1016/J.CMI.2021.06.006
doi: 10.1016/J.CMI.2021.06.006
pubmed: 34129907
Parvizi J, Gehrke T (2014) Definition of periprosthetic joint infection. J Arthroplasty 29:1331. https://doi.org/10.1016/J.ARTH.2014.03.009
doi: 10.1016/J.ARTH.2014.03.009
pubmed: 24768547
Saleh A, George J, Faour M et al (2018) Serum biomarkers in periprosthetic joint infections. Bone Jt Res 7:85–93. https://doi.org/10.1302/2046-3758.71.BJR-2017-0323
doi: 10.1302/2046-3758.71.BJR-2017-0323
Kuo SJ, Huang PH, Chang CC et al (2016) Hepatitis B virus infection is a risk factor for periprosthetic joint infection among males after total knee arthroplasty: a Taiwanese nationwide population-based study. Medicine. https://doi.org/10.1097/MD.0000000000003806
doi: 10.1097/MD.0000000000003806
pubmed: 27930560
pmcid: 5266032
Baek JH, Lee SC, Ryu S et al (2022) Long-term outcomes of primary total knee arthroplasty in patients with hepatitis B virus infection. Bone Jt Open 3:470–474. https://doi.org/10.1302/2633-1462.36.BJO-2022-0030.R1
doi: 10.1302/2633-1462.36.BJO-2022-0030.R1
pubmed: 35673935
pmcid: 9233420
Ross BJ, Cole MW, Ross AJ et al (2023) Hepatitis C is associated with higher short-term complication rates after initial aseptic and septic revision total hip arthroplasty: a matched cohort study. J Arthroplasty 38:548–554. https://doi.org/10.1016/J.ARTH.2022.09.018
doi: 10.1016/J.ARTH.2022.09.018
pubmed: 36130698
Salter ML, Lau B, Mehta SH et al (2013) Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections. J Acquir Immune Defic Syndr 64:488–495. https://doi.org/10.1097/QAI.0B013E3182A7EE2E
doi: 10.1097/QAI.0B013E3182A7EE2E
pubmed: 23978997
Shah S, Ma Y, Scherzer R et al (2015) Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels. AIDS 29:1325–1333. https://doi.org/10.1097/QAD.0000000000000654
doi: 10.1097/QAD.0000000000000654
pubmed: 25870985
Marnell L, Mold C, Du Clos TW (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117:104–111. https://doi.org/10.1016/J.CLIM.2005.08.004
doi: 10.1016/J.CLIM.2005.08.004
pubmed: 16214080